126 related articles for article (PubMed ID: 8653485)
1. Estimating the rate of adverse drug reactions with capture-recapture analysis.
Seeger JD; Schumock GT; Kong SX
Am J Health Syst Pharm; 1996 Jan; 53(2):178-81. PubMed ID: 8653485
[TBL] [Abstract][Full Text] [Related]
2. FDA's sentinel network: a monumental task.
Young D
Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
[No Abstract] [Full Text] [Related]
3. Computerized surveillance for adverse drug events in a pediatric hospital.
Kilbridge PM; Noirot LA; Reichley RM; Heard KM; Dunagan WC; Bailey TC
AMIA Annu Symp Proc; 2008 Nov; ():1004. PubMed ID: 18998917
[TBL] [Abstract][Full Text] [Related]
4. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug event trigger tool: a practical methodology for measuring medication related harm.
Rozich JD; Haraden CR; Resar RK
Qual Saf Health Care; 2003 Jun; 12(3):194-200. PubMed ID: 12792009
[TBL] [Abstract][Full Text] [Related]
6. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
[TBL] [Abstract][Full Text] [Related]
7. Natural language processing to identify adverse drug events.
Gysbers M; Reichley R; Kilbridge PM; Noirot L; Nagarajan R; Dunagan WC; Bailey TC
AMIA Annu Symp Proc; 2008 Nov; ():961. PubMed ID: 18999130
[TBL] [Abstract][Full Text] [Related]
8. IOM panel mulls over adverse-event reporting.
Young D
Am J Health Syst Pharm; 2005 Dec; 62(24):2590-1. PubMed ID: 16333055
[No Abstract] [Full Text] [Related]
9. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
10. The missing link? Using EHRs to extract data on adverse drug events.
Robeznieks A
Mod Healthc; 2007 Feb; 37(7):34. PubMed ID: 17432260
[No Abstract] [Full Text] [Related]
11. Experience with an adverse drug reaction reporting program in a neurology specialty clinic.
Ryan M; Gora-Harper ML; Caldwell F
Ann Pharmacother; 2002 Feb; 36(2):231-5. PubMed ID: 11847939
[TBL] [Abstract][Full Text] [Related]
12. [Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities].
Jacquot J; Gony M; Baudrin D; Chastel X; Montastruc JL; Bagheri H
Therapie; 2012; 67(3):231-6. PubMed ID: 22874489
[TBL] [Abstract][Full Text] [Related]
13. Recognizing, reporting, and reducing adverse drug reactions.
Brown SD; Landry FJ
South Med J; 2001 Apr; 94(4):370-3. PubMed ID: 11332899
[TBL] [Abstract][Full Text] [Related]
14. Monitoring and managing adverse drug reactions.
Fincham JE
Am Pharm; 1992 Feb; NS32(2):74-81. PubMed ID: 1546634
[No Abstract] [Full Text] [Related]
15. Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.
Sarangdhar M; Tabar S; Schmidt C; Kushwaha A; Shah K; Dahlquist JE; Jegga AG; Aronow BJ
Nat Biotechnol; 2016 Jul; 34(7):697-700. PubMed ID: 27404875
[No Abstract] [Full Text] [Related]
16. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
17. Human factors and medical IT systems: complex incident reporting systems and multiple IV infusions.
Colvin C; Baird P; Easty T; Trbovich P
Biomed Instrum Technol; 2013; Suppl():59-63. PubMed ID: 24111773
[No Abstract] [Full Text] [Related]
18. Early identification of adverse drug reactions from search log data.
White RW; Wang S; Pant A; Harpaz R; Shukla P; Sun W; DuMouchel W; Horvitz E
J Biomed Inform; 2016 Feb; 59():42-8. PubMed ID: 26610385
[TBL] [Abstract][Full Text] [Related]
19. Comparison of adverse drug reactions detected by pharmacy and medical records departments.
Johnstone DM; Kirking DM; Vinson BE
Am J Health Syst Pharm; 1995 Feb; 52(3):297-301. PubMed ID: 7749958
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
